Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
Clicks: 223
ID: 273937
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
223 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #4 of 4 articles by views in current drug targets
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Inflammatory bowel diseases (IBD) are chronic, relapsing, and destructive inflammatory disorders of the gastrointestinal
tract. Both Crohn’s disease (CD)...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (20 words).
Try re-searching for a better abstract.
| Reference Key |
allocca2013currentanti-il-6
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mariangela, Allocca;Manol, Jovani;Gionata, Fiorino;Stefan, Schreiber;Silvio, Danese; |
| Journal | current drug targets |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.